Publications | N | Prematurity | Age, mo | Sex | Jaundice | Pale stool | Hepatomegaly | Splenomegaly | Growth failure | Poor outcome | |
---|---|---|---|---|---|---|---|---|---|---|---|
Bruguera et al., 1992 [8] | 4 | 0/4 | 5—144 | F > M | 2/4 | not reported | 4/4 | 2/4 | not reported | 1 D 1 C | |
Chiu et al., 1996 [9] | 4 | not reported | 0—132 | M > F | 4/4 | not reported | 4/4 | 2/4 | 4/4 | 3 D | |
Koçak et al., 1997 [10] | 10 | 1/10 | 0.5 – 36 | M > F | 10/10 | 7/10 | 8/10 | 7/10 | 5/10 | 3 D | |
Yehezkely-Schildkraut et al., 2003 [11] | 10 | 2/8 | 0 – 6 | M > F | 10/10 | 4/10 | 5/10 | not reported | not reported | 2 LF 4 UC | |
De Tommaso et al., 2004 [12] | 11 | 2/11 | 1 – 40 | M > F | 11/11 | 8/11 | 6/11 | 4/11 | 1/11 | 1/11 C + LT | |
Meena et al., 2018 [3] | Non-destructive PILBD | 20 | 7/20 | 4 – 12 | M > F | 18/20 | 10/20 | 20/20 | 19/20 | 11/20 | 3 LT |
Destructive PILBD | 50 | 8/50 | 4 – 97 | M > F | 48/50 | 23/50 | 49/50 | 47/50 | 22/50 | 26 LT | |
Mohanty et al., 2019 [13] | 18 | 1/18 | 1 – 11 | M > F | 3/18 | 12/18 | 2/18 | 7/18 | 50–90% | 1 D |